# Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease

> **NCT01291641** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 342 (actual)

## Conditions studied

- Hyperlipidemias

## Interventions

- **DRUG:** HMG-CoA Reductase Inhibitor
- **DRUG:** Probucol
- **DRUG:** Cilostazol

## Key facts

- **NCT ID:** NCT01291641
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2016-12
- **Final completion:** 2017-03
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2019-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01291641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01291641, "Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01291641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*